TeamViewer (TMV) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
28 Jul, 2026Executive summary
Q2 2026 marked a DEX turnaround and inflection point, driving rapid TeamViewer ONE adoption, strong enterprise momentum, and the highest-value ARR bucket up 11% year-over-year at constant currency.
Major enterprise customers recommitted via larger multi-year agreements, with SMB churn stabilizing to its lowest level since the 1E acquisition.
Strategic ServiceNow partnership, FedRAMP milestone, and multiple analyst recognitions (Gartner, IDC, Frost & Sullivan, PAC) reinforced the platform's leadership and long-term growth prospects.
TeamViewer ONE and AI-driven Autonomous Endpoint Management drove innovation, with 49k customers and 2.8m AI sessions by July 2026.
Sales and marketing underwent restructuring to support new product momentum.
Financial highlights
Q2 2026 revenue was €182.7m, down 1.4% year-over-year at constant currency; ARR was €736.8m, nearly flat year-over-year.
Adjusted EBITDA reached €78.9m (margin 43.2%), down 6% year-over-year; net income rose 33% to €30.1m; adjusted EPS was €0.27.
Levered free cash flow was €40.8m, down 31% year-over-year, with cash conversion at 52%.
Net leverage ratio improved to 2.5x, with a clear path to reach 2.3x by year-end.
Gross margin remained high at 92%, stable year-over-year.
Outlook and guidance
Full-year 2026 guidance reaffirmed: constant currency revenue growth expected in the range of 0–3% and adjusted EBITDA margin around 43%.
ARR growth acceleration anticipated in H2 2026, supported by improving SMB churn and enterprise momentum.
FX headwinds expected to impact full-year revenue growth by -2.4 percentage points.
Latest events from TeamViewer
- Enterprise ARR up 8% cc, profitability strong, and guidance reaffirmed for 2026.TMV
Q1 20266 May 2026 - 5% revenue and 8% EBITDA growth in 2025; 2026 outlook cautious with 0–3% growth target.TMV
Q4 202510 Feb 2026 - Q2 2024 delivered strong growth, high margins, and reaffirmed full-year guidance.TMV
Q2 20242 Feb 2026 - Enterprise momentum and cost discipline drove strong Q3 growth and profitability.TMV
Q3 202416 Jan 2026 - $720M deal creates a DEX leader, targeting double-digit growth and global expansion by 2027.TMV
M&A Announcement11 Jan 2026 - FY 2024 exceeded guidance with strong Enterprise growth, 1E integration, and margin expansion.TMV
Q4 202416 Dec 2025 - Enterprise ARR up 21%, revenue and EBITDA both rise 7% and 20% year-over-year, outlook confirmed.TMV
Q1 202519 Nov 2025 - Q2 revenue up 6% and adjusted EBITDA up 17%, driven by enterprise gains and new product launches.TMV
Q2 202516 Nov 2025 - Q3 delivered 4% growth and 46% margin, but 1E weakness led to lower ARR guidance for 2025.TMV
Q3 202522 Oct 2025